ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,722.26
      -0.19%
      US Tech 100
      19,481.60
      0.34%
      Dow Jones
      41,914.75
      -0.70%
      Brent Oil
      73.19
      -1.84%
      Bitcoin
      63,379.76
      -1.38%
      Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Travere Therapeutics Inc (TVTX) Quote

      Travere Therapeutics Inc

      Travere Therapeutics Inc (TVTX)

      NASDAQ
      14.54
      -0.02
      (-0.14%)
      At close: September 25 4:00PM
      Delayed by 15 minutes
      14.54
      0.01
      ( 0.07% )
      After Hours: 4:51PM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      14.54
      Bid
      13.21
      Ask
      15.80
      Volume
      1,662,479
      14.37 Day's Range 15.19
      5.12 52 Week Range 15.36
      Market Cap
      1.112B
      Previous Close
      14.56
      Open
      14.61
      Last Trade
      21810
      @
      14.54
      (average)
      Last Trade Time
      16:31:58
      Financial Volume
      $ 24,605,899
      VWAP
      14.8007
      Average Volume (3m)
      1,398,573
      Shares Outstanding
      76,491,485
      Dividend Yield
      -
      PE Ratio
      -9.98
      Earnings Per Share (EPS)
      -1.46
      Revenue
      145.24M
      Net Profit
      -111.4M

      About Travere Therapeutics Inc

      Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomer... Travere Therapeutics Inc is a biopharmaceutical company. The company is focused on the development and commercialization of therapies for people living with rare diseases. Its pipeline candidate, sparsentan, is an investigational product candidate in late-stage development for focal segmental glomerulosclerosis (FSGS) and IgA nephropathy (IgAN) - rare kidney disorders that often lead to end-stage kidney disease. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      travere.com
      Headquarters
      Lewes, Delaware, USA
      Founded
      -
      Travere Therapeutics Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker TVTX. The last closing price for Travere Therapeutics was $14.56. Over the last year, Travere Therapeutics shares have traded in a share price range of $ 5.12 to $ 15.36.

      Travere Therapeutics currently has 76,491,485 shares outstanding. The market capitalization of Travere Therapeutics is $1.11 billion. Travere Therapeutics has a price to earnings ratio (PE ratio) of -9.98.

      Ask ADVFN Intelligence (AI)

      Travere Therapeutics (TVTX) Options Flow Summary

      TVTX Options Flow

      Overall Flow

      Bullish

      Net Premium

      671k

      Calls / Puts

      700.00%

      Buys / Sells

      14.29%

      OTM / ITM

      60.00%

      Sweeps Ratio

      12.50%

      TVTX Latest News

      More News

      Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

      SAN DIEGO, Sept. 12, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that on September 10, 2024, the Compensation Committee of its Board of Directors granted...

      September 12 2024
      GlobeNewswire Inc.

      Form 144 - Report of proposed sale of securities

      September 11 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 10 2024
      Edgar (US Regulatory)

      Travere Therapeutics to Present at the 2024 Cantor Global Healthcare Conference

      SAN DIEGO, Sept. 10, 2024 (GLOBE NEWSWIRE) -- Travere Therapeutics, Inc., (NASDAQ: TVTX) today announced that company management will present at the 2024 Cantor Global Healthcare Conference on...

      September 10 2024
      GlobeNewswire Inc.

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 4 - Statement of changes in beneficial ownership of securities

      September 09 2024
      Edgar (US Regulatory)

      Form 144 - Report of proposed sale of securities

      September 09 2024
      Edgar (US Regulatory)
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.362.5387870239814.1815.3614.1219302614.83253456CS
      45.4660.13215859039.0815.368.83223753012.77019292CS
      126.4579.72805933258.0915.367.72139857311.11061753CS
      266.5281.29675810478.0215.365.1213057238.90154246CS
      526.7185.69604086857.8315.365.1213989898.33154639CS
      156-10.11-41.01419878324.6531.655.12110975815.60837892CS
      260-10.61-42.186878727625.1533.08995.12104714716.52551439CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      TBIOTelesis Bio Inc
      $ 4.68
      (101.72%)
      		2.84M
      NCNANuCana PLC
      $ 3.5999
      (18.03%)
      		2.03M
      MUMicron Technology Inc
      $ 108.99
      (13.80%)
      		15.41M
      ICGIntchains Group Ltd
      $ 9.51
      (13.08%)
      		1.09k
      FBIOFortress Biotech Inc
      $ 1.56
      (10.64%)
      		628.45k
      PXDTPixie Dust Technologies Inc
      $ 0.9534
      (-57.81%)
      		2.06k
      AAGRAfrican Agriculture Holdings Inc
      $ 0.0708
      (-46.61%)
      		1.8M
      VSMEVS Media Holdings Ltd
      $ 1.1599
      (-23.69%)
      		560.19k
      MDXHMDxHealth SA
      $ 2.10
      (-17.32%)
      		34.63k
      PGYPagaya Technologies Ltd
      $ 10.32
      (-17.11%)
      		222.37k
      MUMicron Technology Inc
      $ 108.99
      (13.80%)
      		15.41M
      NVDANVIDIA Corporation
      $ 124.419
      (0.74%)
      		8.62M
      INTCIntel Corporation
      $ 23.81
      (1.15%)
      		7.91M
      VTRSViatris Inc
      $ 11.32
      (0.44%)
      		7.41M
      HOLOMicroCloud Hologram Inc
      $ 0.2598
      (7.80%)
      		7.16M

      TVTX Discussion

      View Posts
      Monksdream Monksdream 2 weeks ago
      TVTX under $15
      👍️0
      Monksdream Monksdream 3 months ago
      TVTX under $10
      👍️0
      tw0122 tw0122 5 months ago
      7.46 + 13% Looks good Caanacord $15 buy target. Once it breaks 9.83 on the way to $13. Probably take a few weeks and positive catalysts
      👍️0
      Monksdream Monksdream 5 months ago
      TVTX under $10
      👍️0
      bikaver bikaver 11 months ago
      TVTX.....In at 6.56
      👍️0
      bikaver bikaver 12 months ago
      TVTX.....from 7.65 to 9.24 in 6 days
      👍️0
      bikaver bikaver 1 year ago
      TVTX.....Gambling on a dead cat bounce.....in @ 7.65 AH.
      👍️0
      Stockexpertpro Stockexpertpro 1 year ago
      Watching for the Collapse under 8$ This could get ugly today 7$ probably under 6$ Coming
      👍️0
      alchemytrader alchemytrader 3 years ago
      Arent they all modern day drug dealers?
      👍️0
      cash4 cash4 4 years ago
      Free Martin Shkreli, LMFAO, felon CEO with a 1,5 billion company trading at $32 PPS, you gotta love America, just another modern day Drug Dealer.
      👍️0

      Your Recent History

      NASDAQ
      TVTX
      Travere Therapeutics
      Delayed Upgrade Clock